HLYK.OQBHealthlynked CORP

Form 4: HealthLynked Corp: CEO Michael Dent Reports Acquisition of Convertible Notes and Warrants

Sentiment:

SEC Form 4 Filing

📋All filings for Healthlynked CORP
🔒Login to Follow

CEO Michael Dent reports the acquisition of convertible notes and warrants through a trust, signaling continued investment in HealthLynked Corp.

Capital raiseThe reporting person's trust purchased convertible notes from the Issuer.The reporting person's trust received warrants to purchase shares of Issuer's common stock as warrant coverage in connection with the purchase of secured promissory note with an aggregate face value of $900,000.02 from the Issuer on the transaction date.The reporting person's trust received warrants to purchase shares of Issuer's common stock as partial consideration for a 6-month extension of a previously issued convertible promissory note.

Summary

  • Michael Dent, CEO of HealthLynked Corp, filed a Form 4 detailing transactions related to the company's securities.
  • On September 19, 2024, Dent's trust acquired multiple tranches of 12% convertible notes with a conversion price of $0.0486, totaling $900,000.02.
  • These notes are convertible into common stock and have expiration dates ranging from January 10, 2025, to March 10, 2025.
  • The trust also received warrants to purchase 9,259,258 shares of common stock on September 19, 2024, and 356,063 shares of common stock on September 17, 2024, with exercise prices of $0.0486 and $0.0465 respectively.
  • These warrants expire on September 17, 2034, and September 16, 2034, respectively.
  • The warrants were received as warrant coverage for the purchase of a secured promissory note and as partial consideration for a 6-month extension of a previously issued convertible promissory note.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The CEO's investment signals confidence, but the use of convertible notes with a high interest rate could indicate financial constraints.

Positives

  • The CEO's investment in convertible notes demonstrates confidence in the company's future.
  • The warrant coverage provides potential for future equity upside.

Risks

  • Conversion of the notes could dilute existing shareholders.
  • The high interest rate of 12% on the convertible notes could indicate difficulty in obtaining financing through conventional means.

Future Outlook

The document does not contain explicit forward-looking statements, but the acquisition of convertible notes and warrants suggests continued investment in the company's growth.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders. The acquisition of convertible notes and warrants is a common financing strategy for growth-stage companies.

Stakeholder Impact

  • Shareholders may experience dilution if the convertible notes are converted into common stock.
  • The company's financial stability could be affected by the high interest rate on the convertible notes.

Key Dates

DateDescription
January 31, 2006Date of the Mary S. Dent Gifting Trust
September 16, 2024Date warrants for 356,063 shares were granted.
September 17, 2024Date of earliest transaction reported.
September 17, 2034Expiration date of warrants for 9,259,258 shares.
September 18, 2024Date warrants for 9,259,258 shares were granted.
September 19, 2024Date of convertible note and warrant acquisitions.
January 10, 2025Expiration date of some convertible notes.
January 16, 2025Expiration date of some convertible notes.
January 19, 2025Expiration date of some convertible notes.
January 30, 2025Expiration date of some convertible notes.
February 14, 2025Expiration date of some convertible notes.
February 20, 2025Expiration date of some convertible notes.
February 28, 2025Expiration date of some convertible notes.
March 04, 2025Expiration date of some convertible notes.
March 10, 2025Expiration date of some convertible notes.
September 16, 2034Expiration date of warrants for 356,063 shares.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.